$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams

$ams Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923014203 Filed on May 12, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q4
Revenue	$5.568M	$4.925M	$5.037M
YoY Change	10.61%	1.61%	7.42%
Cost Of Revenue	$3.050M	$3.017M	$2.767M
YoY Change	3.53%	8.53%	11.98%
Gross Profit	$2.518M	$1.908M	$2.270M
YoY Change	20.59%	-7.69%	2.34%
Gross Profit Margin	45.22%	38.74%	45.07%
Selling, General & Admin	$1.988M	$1.539M	$1.420M
YoY Change	73.47%	16.68%	14.7%
% of Gross Profit	78.95%	80.66%	62.56%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.242M	$1.367M	$1.226M
YoY Change	6.79%	12.79%	0.33%
% of Gross Profit	49.32%	71.65%	54.01%
Operating Expenses	$1.988M	$1.539M	$1.420M
YoY Change	73.47%	16.68%	14.7%
Operating Profit	-$325.0K	$98.00K	$850.0K
YoY Change	-140.98%	-83.67%	-13.27%
Interest Expense	$277.0K	$271.0K	-$204.0K
YoY Change	85.91%	83.11%	31.61%
% of Operating Profit		276.53%	-24.0%
Other Income/Expense, Net
YoY Change
Pretax Income	-$212.0K	$168.0K	$646.0K
YoY Change	-126.9%	-72.0%	-10.28%
Income Tax	-$35.00K	$68.00K	$333.0K
% Of Pretax Income		40.48%	51.55%
Net Earnings	-$111.0K	$188.0K	$246.0K
YoY Change	-122.33%	-30.11%	12.33%
Net Earnings / Revenue	-1.99%	3.82%	4.88%
Basic Earnings Per Share	-$0.02	$0.03
Diluted Earnings Per Share	-$0.02	$0.03	$0.04
COMMON SHARES
Basic Shares Outstanding	6.214M	6.184M	6.153M
Diluted Shares Outstanding	6.336M	6.472M

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.68M	$13.08M	$12.34M
YoY Change	15.42%	57.95%	51.44%
Cash & Equivalents	$13.68M	$13.08M	$12.34M
Short-Term Investments
Other Short-Term Assets	$1.081M	$1.715M	$2.260M
YoY Change	22.15%	10.08%	6.7%
Inventory
Prepaid Expenses
Receivables	$4.690M	$4.369M	$3.801M
Other Receivables	$636.0K	$404.0K	$327.0K
Total Short-Term Assets	$20.08M	$19.57M	$18.72M
YoY Change	19.26%	28.42%	24.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$22.99M	$22.55M	$23.80M
YoY Change	-12.48%	-18.31%	-17.71%
Goodwill	$1.265M	$1.265M	$1.265M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$78.00K	$78.00K	$78.00K
YoY Change	0.0%	0.0%	0.0%
Long-Term Investments
YoY Change
Other Assets	$38.00K	$86.00K	$87.00K
YoY Change	-45.71%	19.44%	19.18%
Total Long-Term Assets	$24.37M	$23.98M	$25.23M
YoY Change	-11.96%	-17.37%	-16.84%
TOTAL ASSETS
Total Short-Term Assets	$20.08M	$19.57M	$18.72M
Total Long-Term Assets	$24.37M	$23.98M	$25.23M
Total Assets	$44.46M	$43.55M	$43.96M
YoY Change	-0.15%	-1.6%	-3.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$297.0K	$254.0K	$230.0K
YoY Change	104.83%	-35.86%	-27.67%
Accrued Expenses	$2.275M	$2.219M	$2.571M
YoY Change	19.86%	-6.92%	-19.93%
Deferred Revenue	$554.0K	$473.0K	$0.00
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.264M	$1.262M	$1.262M
YoY Change	-22.97%	-23.19%	16.74%
Total Short-Term Liabilities	$6.756M	$5.254M	$5.175M
YoY Change	45.92%	9.03%	-12.15%
LONG-TERM LIABILITIES
Long-Term Debt	$11.08M	$11.49M	$12.21M
YoY Change	-17.94%	-16.26%	-14.79%
Other Long-Term Liabilities	$58.00K	$89.00K	$129.0K
YoY Change	-77.52%	-77.24%	-74.15%
Total Long-Term Liabilities	$11.08M	$11.49M	$12.21M
YoY Change	-17.94%	-16.26%	-14.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.756M	$5.254M	$5.175M
Total Long-Term Liabilities	$11.08M	$11.49M	$12.21M
Total Liabilities	$18.72M	$17.73M	$18.33M
YoY Change	-2.46%	-4.41%	-13.5%
SHAREHOLDERS EQUITY
Retained Earnings	$3.096M	$3.207M	$3.019M
YoY Change	26.01%	63.62%	78.53%
Common Stock	$18.80M	$18.70M	$18.61M
YoY Change	2.36%	148.33%	2.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$21.90M	$21.91M	$21.63M
YoY Change
Total Liabilities & Shareholders Equity	$44.46M	$43.55M	$43.96M
YoY Change	-0.15%	-1.6%	-3.24%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q4
OPERATING ACTIVITIES
Net Income	-$111.0K	$188.0K	$246.0K
YoY Change	-122.33%	-30.11%	12.33%
Depreciation, Depletion And Amortization	$1.242M	$1.367M	$1.226M
YoY Change	6.79%	12.79%	0.33%
Cash From Operating Activities	$3.453M	$1.761M	$1.602M
YoY Change	-9.91%	579.92%	-48.72%
INVESTING ACTIVITIES
Capital Expenditures	$2.352M	$209.0K	$56.00K
YoY Change	-7940.0%	216.67%	-104.22%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$2.352M	-$209.0K	-$56.00K
YoY Change	7740.0%	216.67%	-95.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$730.0K
YoY Change		1227.27%
Cash From Financing Activities	-508.0K	-$804.0K	-757.0K
YoY Change	114.35%	1361.82%	7.83%
NET CHANGE
Cash From Operating Activities	3.453M	$1.761M	1.602M
Cash From Investing Activities	-2.352M	-$209.0K	-56.00K
Cash From Financing Activities	-508.0K	-$804.0K	-757.0K
Net Change In Cash	593.0K	$748.0K	789.0K
YoY Change	-83.37%	442.03%	-27.95%
FREE CASH FLOW
Cash From Operating Activities	$3.453M	$1.761M	$1.602M
Capital Expenditures	$2.352M	$209.0K	$56.00K
Free Cash Flow	$1.101M	$1.552M	$1.546M
YoY Change	-71.5%	704.15%	-65.27%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	230000	usd
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6184000
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6184000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6184000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6184000
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	18000	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-08789
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-2918118
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	601 Montgomery Street
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94111-2619
CY2023Q1	dei	City Area Code CityAreaCode	415
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	788-5300
CY2023Q1	dei	Security12b Title Security12bTitle	American Shared Hospital Services Common Stock, No Par Value
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	526000	usd
CY2023Q1	dei	Trading Symbol TradingSymbol	AMS
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	735000	usd
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1478000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1544000	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6214000
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13083000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12335000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	118000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	118000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4369000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3801000	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	404000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	327000	usd
CY2023Q1	ams	Prepaid Maintenance Current PrepaidMaintenanceCurrent	816000	usd
CY2022Q4	ams	Prepaid Maintenance Current PrepaidMaintenanceCurrent	1245000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	781000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	897000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	19571000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	18723000	usd
CY2023Q1	ams	Property Plant And Equipment Net Excluding Land PropertyPlantAndEquipmentNetExcludingLand	22296000	usd
CY2022Q4	ams	Property Plant And Equipment Net Excluding Land PropertyPlantAndEquipmentNetExcludingLand	23467000	usd
CY2023Q1	us-gaap	Land Land	19000	usd
CY2022Q4	us-gaap	Land Land	19000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	1265000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1265000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	232000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	317000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	78000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	78000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	86000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	87000	usd
CY2023Q1	us-gaap	Assets Assets	43547000	usd
CY2022Q4	us-gaap	Assets Assets	43956000	usd
CY2023Q1	ams	Asset Retirement Obligation Related Party Current AssetRetirementObligationRelatedPartyCurrent	360000	usd
CY2022Q4	ams	Asset Retirement Obligation Related Party Current AssetRetirementObligationRelatedPartyCurrent	360000	usd
CY2023Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	255000	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	255000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	473000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	215000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	292000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1262000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1262000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5254000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5175000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	36000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	59000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11493000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12205000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	53000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	70000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	890000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	822000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	17726000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	18331000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	10763000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10763000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7939000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7843000	usd
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3207000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3019000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	21909000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	21625000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	3912000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	4000000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25821000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25625000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	254000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43547000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43956000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4925000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4847000	usd
CY2023Q1	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	486000	usd
CY2022Q1	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	440000	usd
CY2023Q1	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	1357000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	123000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	96000	usd
CY2022Q1	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	1187000	usd
CY2023Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	879000	usd
CY2022Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	884000	usd
CY2023Q1	ams	Other Cost Of Operating Revenue Related Party OtherCostOfOperatingRevenueRelatedParty	295000	usd
CY2022Q1	ams	Other Cost Of Operating Revenue Related Party OtherCostOfOperatingRevenueRelatedParty	269000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	3017000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	2780000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1908000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	2067000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1539000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1319000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	271000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	148000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	98000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	600000	usd
CY2023Q1	ams	Interest And Other Income Loss InterestAndOtherIncomeLoss	70000	usd
CY2022Q1	ams	Interest And Other Income Loss InterestAndOtherIncomeLoss	0	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	168000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	600000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	68000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	206000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	100000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	394000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-88000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	125000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	188000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	269000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6306000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6201000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6472000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6299000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24239000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	87000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	394000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24720000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25625000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	96000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	100000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25821000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	100000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	394000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1367000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1212000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	18000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	18000	usd
CY2023Q1	ams	Noncash Lease Expense NoncashLeaseExpense	85000	usd
CY2022Q1	ams	Noncash Lease Expense NoncashLeaseExpense	83000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	68000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	87000	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	3000	usd
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	9000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	634000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	575000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-548000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-567000	usd
CY2023Q1	ams	Increase Decrease In Asset Retirement Obligations Related Party IncreaseDecreaseInAssetRetirementObligationsRelatedParty	0	usd
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0554	pure
CY2022Q1	ams	Increase Decrease In Asset Retirement Obligations Related Party IncreaseDecreaseInAssetRetirementObligationsRelatedParty	-457000	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-66000	usd
CY2022Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-805000	usd
CY2023Q1	ams	Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue	279000	usd
CY2022Q1	ams	Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue	-297000	usd
CY2023Q1	ams	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-103000	usd
CY2022Q1	ams	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-100000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1761000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	259000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	209000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	66000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-209000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-66000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	730000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	55000	usd
CY2023Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	74000	usd
CY2022Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	-0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-804000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-55000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	748000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	138000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12453000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8263000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13201000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8401000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	253000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	130000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	20000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	55000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13083000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8283000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	118000	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	118000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13201000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8401000	usd
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0578	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	143000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.80
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	48000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.73
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4925000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4847000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	188000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	269000	usd
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<b>Reclassification</b> - Certain comparative balances as of and for the <em style="font: inherit;">three</em>-month period ended <em style="font: inherit;"> March 31, 2022</em> have been reclassified to make them consistent with the current period presentation.
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	74425000	usd
CY2022Q4	ams	Property Plant And Equipment Gross Excluding Land PropertyPlantAndEquipmentGrossExcludingLand	74237000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	52129000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	50770000	usd
CY2023Q1	ams	Property Plant And Equipment Net Excluding Land PropertyPlantAndEquipmentNetExcludingLand	22296000	usd
CY2022Q4	ams	Property Plant And Equipment Net Excluding Land PropertyPlantAndEquipmentNetExcludingLand	23467000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	18000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	181000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	198000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	12755000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	181000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	915000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2094000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2469000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	7294000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	164000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	12936000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	67000
CY2022Q1	us-gaap	Lease Cost LeaseCost	57000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	103000	usd
CY2023Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	363000	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	591000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	174000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	92000	usd
CY2023Q1	ams	Accrued Operating Costs Current AccruedOperatingCostsCurrent	620000	usd
CY2022Q4	ams	Accrued Operating Costs Current AccruedOperatingCostsCurrent	539000	usd
CY2023Q1	ams	Accrued Liabilites Other Current AccruedLiabilitesOtherCurrent	321000	usd
CY2022Q4	ams	Accrued Liabilites Other Current AccruedLiabilitesOtherCurrent	322000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1478000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1544000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	232000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	251000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	198000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	59000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	257000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	251000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	103000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	50000	usd
CY2022Q1	us-gaap	Sublease Income SubleaseIncome	43000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	53000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	100000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y11M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.72
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M29D
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	188000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	269000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6306000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6201000
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	166000
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	98000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6472000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6299000
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	95000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.76
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M29D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	50000
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.93
CY2023Q1	ams	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P7Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2000
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.90
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	67000
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.72
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y1M2D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	59000
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.72
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y9M7D

Files In Submission

Name	View Source	Status
ams-20230331_pre.xml	Edgar Link	unprocessable
ams-20230331_lab.xml	Edgar Link	unprocessable
0001437749-23-014203-index-headers.html	Edgar Link	pending
0001437749-23-014203-index.html	Edgar Link	pending
0001437749-23-014203.txt	Edgar Link	pending
0001437749-23-014203-xbrl.zip	Edgar Link	pending
ams-20230331.xsd	Edgar Link	pending
asha20230331_10q.htm	Edgar Link	pending
ex_462906.htm	Edgar Link	pending
ex_462907.htm	Edgar Link	pending
ex_462908.htm	Edgar Link	pending
ex_517165.htm	Edgar Link	pending
ex_517760.htm	Edgar Link	pending
ex_517761.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
ams-20230331_cal.xml	Edgar Link	unprocessable
ams-20230331_def.xml	Edgar Link	unprocessable
asha20230331_10q_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams

2023 Q2 Form 10-Q Financial Statement

#000143774923014203 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMS AMERICAN SHARED HOSPITAL SERVICES Stock $ams

2023 Q2 Form 10-Q Financial Statement

#000143774923014203 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams